The influence of sildenafil on random skin flap survival in rats: An experimental study

British Journal of Plastic Surgery

Volumn 57, Issue 8, 2004, Pages 769-772

  Sarifakioglu, Nedim ^a,b   Gokrem, Serdar ^a   Ates, Levent ^a   Akbuga, Unzile B ^a   Aslan, Gürcan ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Flap survival; PDE inhibitors; Sildenafil; Skin flap

Indexed keywords

AMRINONE; ENOXIMONE; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR; SILDENAFIL; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DYSPEPSIA; FLUSHING; GRAFT SURVIVAL; HEADACHE; HUMAN; MALE; NONHUMAN; NOSE CONGESTION; PRIORITY JOURNAL; RANDOMIZATION; RAT; RAT STRAIN; SIDE EFFECT; SINGLE DRUG DOSE; SKIN FLAP; SKIN NECROSIS; STATISTICAL SIGNIFICANCE; SURVIVAL; THROMBOCYTE AGGREGATION INHIBITION; VASODILATATION;

ANIMALS; GRAFT SURVIVAL; MALE; NECROSIS; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; SKIN TRANSPLANTATION; SURGICAL FLAPS;

EID: 8644256873     PISSN: 00071226     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjps.2004.04.014     Document Type: Article

References (20)

1. Glossmann H. Petrischor G. Bartsch G. Molecular mechanisms of the effects of sildenafil (VIAGRA) Exp Gerontol 34 3 1999 305-318
2. Michelakis E. Tymchak W. Archer S. Sildenafil: From the bench to the bedside CMAJ 163 9 2000 1171-1175
3. Boolell M. Gepi-Attee S. Gingell J.C. Allen M.J. Sildenafil, a novel effective oral therapy for male erectile dysfunction Br J Urol 78 2 1996 257-261
4. Rendell M.S. Rajfer J. Wicker P.A. Smith M.D. Sildenafil for treatment of erectile dysfunction in men with diabetes: A randomized controlled trial. Sildenafil Diabetes Study Group JAMA 281 5 1999 421-426
5. Moreira S.G. Jr Brannigan R.E. Spitz A. Orejuela F.J. Lipshultz L.I. Kim E.D. Side-effect profile of sildenafil citrate (Viagra) in clinical practice Urology 56 3 2000 474-476
6. Chetlin M.D. Hutter A.M. Jr Brindis R.G. Ganz P. Kaul S. Russel R.O. Jr et al. ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Hearth Association J Am Coll Cardiol 33 1998 273-282
7. Lim P.H.C. Moorthy P. Benton K.G.F. The clinical safety of Viagra In: Chiueh C.C. Hong J.S. Leong S.K. (Eds.) Annals of The New York Academy of Sciences Nitric oxide: Novel actions, deleterious effects, and clinical potential vol. 962 2002 379-388 The New York Academy of Sciences New York
8. Snedecor G.W. Cochran W.G. Statistical Methods 7th ed Ames 1980 The Iowa State Univ. Press Iowa
9. Raposio E. Santi P.L. Pharmacological enhancement of cutaneous flap survival with topical dimethyl sulphoxide and hydrogen peroxide Br J Plast Surg 51 7 1998 551-554
10. Andersson K.E. Hedlund P. New directions for erectile dysfunction therapies Int J Impot Res 14 Suppl 1 2002 S82-S92
11. Wang G.R. Zhu Y. Halushka P.V. Lincoln T.M. Mendelsohn M.E. Mechanism of platelet inhibition by nitric oxide: In vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase Proc Natl Acad Sci USA 95 1998 4888-4893
12. Goldstein I. Lue T.F. Padma-Nathan H. Rosen R.C. Steers W.D. Wicker P.A. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group N Engl J Med 338 20 1998 1397-1404
13. Goldenberg M.M. Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction Clin Ther 20 6 1998 1033-1048
14. Conti C.R. Pepine C.J. Sweeney M. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease Am J Cardiol 83 5A 1999 29C-34C
15. Moreira S.G. Jr Brannigan R.E. Spitz A. Orejuela F.J. Lipshultz L.I. Kim E.D. Side-effect profile of sildenafil citrate (Viagra) in clinical practice Urology 56 3 2000 474-476
16. Ichioka S. Nakatsuka T. Sato Y. Shibata M. Kamiya A. Harii K. Amrinone, a selective phosphodiesterase III inhibitor, improves microcirculation and flap survival: A comparative study with prostaglandin E1 J Surg Res 75 1 1998 42-48
17. Ichioka S. Nakatsuka T. Ohura N. Sato Y. Harii K. Topical application of amrinone (a selective phosphodiesterase III inhibitor) for relief of vasospasm J Surg Res 93 1 2000 149-155
18. Ichioka S. Nakatsuka T. Ohura N. Sato Y. Harii K. Clinical use of amrinone (a selective phosphodiesterase III inhibitor) in reconstructive surgery Plast Reconstr Surg 108 7 2001 1931-1937
19. Grossmann M. Braune J. Ebert U. Kirch W. Dilatory effects of phosphodiesterase inhibitors on human hand veins in vivo Eur J Clin Pharmacol 54 1 1998 35-39
20. Zhong A. Pang C.Y. Sheffield W.D. Morris S.F. Forrest C.R. Augmentation of acute random pattern skin flap viability in the pig J Surg Res 52 2 1992 177-183